G1 Therapeutics, Inc.

NasdaqGS:GTHX 주식 보고서

시가총액: US$378.2m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

G1 Therapeutics 미래 성장

Future 기준 확인 6/6

G1 Therapeutics (는) 각각 연간 51.6% 및 24.3% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 52.7% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 33.4% 로 예상됩니다.

주요 정보

67.2%

수익 성장률

68.3%

EPS 성장률

Biotechs 수익 성장28.4%
매출 성장률36.1%
향후 자기자본 수익률33.4%
애널리스트 커버리지

Low

마지막 업데이트18 Sep 2024

최근 미래 성장 업데이트

G1 Therapeutics, Inc. (NASDAQ:GTHX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

May 04
G1 Therapeutics, Inc. (NASDAQ:GTHX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Recent updates

There's No Escaping G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Muted Revenues Despite A 80% Share Price Rise

Jul 26
There's No Escaping G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Muted Revenues Despite A 80% Share Price Rise

G1 Therapeutics: Failure Of Breast Cancer Underscores Long-Term Uncertainty

Jun 24

Shareholders May Not Be So Generous With G1 Therapeutics, Inc.'s (NASDAQ:GTHX) CEO Compensation And Here's Why

Jun 07
Shareholders May Not Be So Generous With G1 Therapeutics, Inc.'s (NASDAQ:GTHX) CEO Compensation And Here's Why

Little Excitement Around G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Revenues

May 28
Little Excitement Around G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Revenues

G1 Therapeutics, Inc. (NASDAQ:GTHX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

May 04
G1 Therapeutics, Inc. (NASDAQ:GTHX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Why G1 Therapeutics Is A Speculative 'Buy' In The Oncology Biotech Landscape

Mar 22

Why Investors Shouldn't Be Surprised By G1 Therapeutics, Inc.'s (NASDAQ:GTHX) 44% Share Price Plunge

Feb 27
Why Investors Shouldn't Be Surprised By G1 Therapeutics, Inc.'s (NASDAQ:GTHX) 44% Share Price Plunge

Does G1 Therapeutics (NASDAQ:GTHX) Have A Healthy Balance Sheet?

Feb 06
Does G1 Therapeutics (NASDAQ:GTHX) Have A Healthy Balance Sheet?

G1 Therapeutics, Inc. (NASDAQ:GTHX) Stock Catapults 61% Though Its Price And Business Still Lag The Industry

Jan 04
G1 Therapeutics, Inc. (NASDAQ:GTHX) Stock Catapults 61% Though Its Price And Business Still Lag The Industry

Little Excitement Around G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Revenues

Jun 08
Little Excitement Around G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Revenues

New Forecasts: Here's What Analysts Think The Future Holds For G1 Therapeutics, Inc. (NASDAQ:GTHX)

May 08
New Forecasts: Here's What Analysts Think The Future Holds For G1 Therapeutics, Inc. (NASDAQ:GTHX)

The G1 Therapeutics, Inc. (NASDAQ:GTHX) Analysts Have Been Trimming Their Sales Forecasts

Nov 04
The G1 Therapeutics, Inc. (NASDAQ:GTHX) Analysts Have Been Trimming Their Sales Forecasts

G1 Therapeutics: Catalysts Stacking

Oct 20

G1 Therapeutics: Building A Franchise

Sep 29

Analysts Just Published A Bright New Outlook For G1 Therapeutics, Inc.'s (NASDAQ:GTHX)

Aug 04
Analysts Just Published A Bright New Outlook For G1 Therapeutics, Inc.'s (NASDAQ:GTHX)

G1 Therapeutics Q2 2022 Earnings Preview

Aug 02

G1 Therapeutics: Take Advantage Of The November Data

Jul 22

수익 및 매출 성장 예측

NasdaqGS:GTHX - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/20264773029654873
12/31/202589-11-563
12/31/202471-24-30-151
6/30/202458-45-38-38N/A
3/31/202484-31-18-18N/A
12/31/202383-48-38-38N/A
9/30/202378-71-56-56N/A
6/30/202389-78-67-67N/A
3/31/202357-126-120-119N/A
12/31/202251-148-129-129N/A
9/30/202247-154-133-133N/A
6/30/202228-171-146-145N/A
3/31/202224-171-143-143N/A
12/31/202131-148-132-132N/A
9/30/202142-134-129-129N/A
6/30/202164-103-91-91N/A
3/31/202160-95-84-84N/A
12/31/202045-99-84-84N/A
9/30/202029-109-83-82N/A
6/30/20202-130-113-111N/A
3/31/2020N/A-130-108-105N/A
12/31/2019N/A-122-102-100N/A
9/30/2019N/A-111-93-91N/A
6/30/2019N/A-99-83-82N/A
3/31/2019N/A-89-79-78N/A
12/31/2018N/A-85-75-74N/A
9/30/2018N/A-78-68-68N/A
6/30/2018N/A-74-65-65N/A
3/31/2018N/A-68N/A-59N/A
12/31/2017N/A-65N/A-51N/A
9/30/2017N/A-60N/A-45N/A
6/30/2017N/A-52N/A-37N/A
3/31/2017N/A-45N/A-29N/A
12/31/2016N/A-35N/A-25N/A
12/31/20151-22N/A-14N/A
12/31/20141-7N/A-6N/A

애널리스트 미래 성장 예측

수입 대 저축률: GTHX 은 향후 3년 동안 수익을 낼 것으로 예상되며, 이는 절약률( 2.5% )보다 빠른 성장으로 간주됩니다.

수익 vs 시장: GTHX (는) 향후 3년 동안 평균 시장 성장보다 높은 수익을 올릴 것으로 예상됩니다.

고성장 수익: GTHX 향후 3년 내에 수익을 낼 것으로 예상됩니다.

수익 대 시장: GTHX 의 수익(연간 24.3% ) US 시장( 8.8% 보다 빠르게 성장할 것으로 예상됩니다. 8.8% 연간).

고성장 수익: GTHX 의 수익(연간 24.3% )은 연간 20% 보다 빠르게 증가할 것으로 예상됩니다.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: GTHX 의 자본 수익률은 3년 내에 최고 수준이 될 것으로 예상됩니다. ( 33.4 %)


성장 기업 발견